Marie E. Pinizzotto M.D. ’08M and Carol A. Ammon
Speaking to their lifelong passion for and dedication to health care innovation and medical research, Carol Ammon and Marie Pinizzotto made a transformative $25 million gift in November 2017 to establish the Ammon Pinizzotto Biopharmaceutical Innovation Center on UD’s STAR Campus. This gift follows their generous $1 million gift in 2013 to support the College of Health Sciences complex, also on the STAR campus. That same year, Carol was the benefactor responsible for the largest individual gift in the history of Christiana Care, with a gift to the Wilmington Hospital Transformation Project.
Carol is retired as the founder of Endo Pharmaceuticals Inc. and has served as on UD’s Board of Trustees since 2013. She previously served as a trustee and chair of the board of Christiana Care and a member of the Healthcare Initiative Advisory Board at Harvard. She’s the recipient of the 2018 Pete du Pont Freedom Award, celebrated for her success in launching Endo Pharmaceuticals, Inc. and its impact on Delaware over the ensuing twenty-plus years along with her philanthropic work to help transform Wilmington Hospital into a state-of-the-art center of healing and compassion.
Marie is the chief executive officer and executive director of the Carol A. Ammon Foundation and has held numerous executive positions in the pharmaceutical and women’s health industries after a career in Delaware practicing medicine. She also sits on numerous nonprofit boards and is the named chair of OB/GYN at Christiana Care Health Systems. Marie earned her medical degree from Thomas Jefferson University’s Sidney Kimmell School of Medicine, where she currently sits on the President’s Leadership Council, and her MBA at UD in 2008, and has served on the College of Health Sciences Advisory Council.